InvestorsHub Logo
Followers 50
Posts 9222
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Wednesday, 10/26/2022 12:04:42 AM

Wednesday, October 26, 2022 12:04:42 AM

Post# of 13613
In over ten years since our inception, Moderna has transformed from an infectious disease-focused company advancing programs in the field mRNA to a company with a diverse portfolio of vaccines and therapeutics across seven modalities.




WINNER$$$$$$$
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News